68
Participants
Start Date
April 18, 2023
Primary Completion Date
August 22, 2025
Study Completion Date
September 11, 2025
50561 high dose
study drug
50561 low dose
study drug
Placebo
Non-active study drug
Xuanwu Hospital, Capital Medical University, Beijing
Beijing Anding Hospital, Capital Medical University, Beijing
Beijing Friendship Hospital, Capital Medical University, Beijing
Beijing Tiantan Hospital, Capital Medical University, Beijing
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou
Heilongjiang Provincial Hospital of Traditional Chinese Medicine, Haerbin
Wuhan Union Hospital of China, Wuhan
The Second Affiliated Hospital of Nanjing Medical University, Nanjing
The First affiliated hospital of SOOCHOW university, Suzhou
The First Bethune Hospital of Jilin University, Changchun
Tianjin Huanhu Hospital, Tianjin
Sir Run Run Shaw Hospital, Hangzhou
Lead Sponsor
Beijing Joekai Biotechnology LLC
INDUSTRY